Meditation and Psychotherapy: Learning from Non-Ordinary States

Event description
Sponsored by BSAS
No

Non-ordinary states of consciousness (dreams, hypnosis, meditation, breath regulation) are a familiar aspect of psychotherapy. Recently, pharmaceutical psychedelics, such as MDMA, psilocybin, and ketamine, are being used in trials in the US and abroad to enhance psychotherapy for disorders such as PTSD, depression, and addictions. Understanding the common and divergent change processes in meditation practices, psychedelic treatment, and other methods of evoking non-ordinary states offers clinicians and researchers an opportunity to understand more deeply how psychological disorders are created and alleviated. This course will explore the history, science, neurobiology, ethical, and legal issues involved when working with non-ordinary states of consciousness, especially psychedelics.

Speakers/Topics include:

  • Michael Alpert (non-ordinary states of consciousness )
  • Deirdre Barrett (dreams)
  • Judson Brewer (neurobiology)
  • Elizabeth Call and Susan Walker (ketamine)
  • Rick Doblin (psychedelic history/science)
  • Christopher Germer and Ronald Siegel (clinical perspectives)
  • Carol Ginandes (hypnosis)
  • Francis Guerriero (psychedelic experiences)
  • James Hopper (MDMA/trauma)
  • Inna Khazan and Nicholas Luchetti (holotropic breathing)
  • Franklin King (the future of psychedelics)
  • Andrew Olendzki (Buddhist meditation)
  • Janis Phelps (learning psychedelic-assisted psychotherapy)
  • William Richards (psilocybin)
  • Carmel Shachar (law/ethics)
  • Paul Summergrad (spiritual experiences)
Details
Presenter
Multiple
Event date
to
Attendance mode
In Person
Address

Hyatt Regency Boston
1 Ave de Lafayette
Boston, MA 02111
United States

Cost
Physicians $425 All Others: $310
Contact
Judy Reiner Platt and Jared Katz
Phone
617-806-8770
Position
Director, Continuing Education and Coordinator
Organization
Cambridge Health Alliance
meditation course.pdf